The qualitative and quantitative findings are merged and displayed jointly to support each other under the five thematic areas that emerged: (1) Record keeping and surveillance for NCDs; (2) availability of NCD services; (3) perceived needs for improving NCD care; (4) limited NCD focused implementation research engagement; (5) and opportunities for improving NCD focused implementation research.
Record keeping and surveillance for NCDs
The record keeping system in most of the facilities was not rigorous to detail the prevelance of NCDs or their risk factors. At the time of the assessment, 20/22 (91%) of the facilities did not have an NCD register for new cases, followups or admissions. The record keeping system however could not give facility disease prevalence because some patients were counted multiple times for each visit they made to the facility (for the same or different condition) in that year. We were also unable to obtain information on all cases seen in the past year for any other ailments to get a denominator for calculating the prevalence. Outpatient logging available from 19 (87%) of the facilities however showed that in the previous year, hypertension was the most common seen condition contributing 44.6% of the NCD cases we targeted, followed by diabetes at 37.7% (figure 1).
Although it was not possible to establish the prevalence of different NCDs from the available data, the healthcare workers perceived that NCDs were on the increase in the country and within their facilities’ catchment areas. Lifestyle habits such as poor diet and sedentary life were some of the perceived contributing factors.
“I don’t have the actual statistics, but I think cardiovascular problems [. . .] hypertension, are the biggest problem in Malawi. However, I realize that mental health problems are an emerging issue in the field of NCDs [ . . .] hypertension it would be because of lifestyle, the food we eat. I have no data but I have the feeling people use quite a lot of salt in our setting. I think that contributes significantly to the incidence of hypertension” (Participant 36, central hospital director)
“At [this facility] we have a lot of hypertension patients, diabetes patients, cancer patients, and a few of sickle cell [. . .] I think a lot of it is because of the food we eat. Most the things we eat are genetically modified, so I think they are the major contributing factor” (participant 38, central hospital pharmacist).
Availability of NCD Services
We assessed availability of screening, diagnosis, management and rehabilitation services for NCDs at the primary, secondary and tertiary level health facilities. NCD services offered at the facilities varied depending on availability of human resources, equipment and medicines. Fifteen (68%) facilities indicated that they routine NCD clinics. Sixty-eight percent (68% ) of the facilities had a joint NCD clinic which catered for clients with hypertension, diabetes, asthma and epilepsy. Cardiology and renal clinics were only available at tertiary facilities. None of the facilities had a specific clinic for cardiology, asthma or COPD, however, clients with these conditions were reviewed at general medicine, chest or NCD clinics available at the facilities. Table 2 shows the availability of NCD services according to categories of the health facilities.
Table 2: Availability of NCD Clinics at primary, secondary and tertiary health facilities
Disease/condition
|
Central hospital N = 4
|
District Hospital N= 2
|
Health centre
N = 16
|
Total
N = 22
|
Diabetes
|
3 (75%)
|
2 (100%)
|
6 (38%)
|
11 (50%)
|
Hypertension
|
3 (75%)
|
2 (100%)
|
10 (63%)
|
15 (68%)
|
Cardiology
|
2 (50%)*
|
0 (0%)
|
0 (0%)
|
2 (9%)
|
Asthma/COPD
|
2 (50%)*
|
0 (0%)
|
2 (13%)#
|
4 (18%)
|
Renal
|
2 (50%)
|
0 (0%)
|
0 (0%)
|
2 (9%)
|
Key: *The clinic was part of general medicine or chest clinic; # The clinic was part of the joint NCD clinic
The services offered at these clinics included weight and blood pressure measurement, glucose checking (at diabetes clinics only) and medication refill. Monitoring for kidney function was not routinely done except for the renal clinic or in exceptional circumstances where renal problem was suspected. The participants observed that the NCD care services currently being offered were not adequate at all levels of care:
“All of us are just at curative level. So structures at community level are not there, that’s my observation. We all seem to be running around doing curative care so to say. People have said, ‘Prevention is better than cure’, so preventive components, there isn’t good structures out there [ . . .] you find that someone will be having headache and they will just be taking Panadol. Without even going for just normal screening. But I cannot blame them. Because those structures, just for normal screening are not there [. . . ] like going from house hold to house hold, like what is happening with HIV. I understand there are structures for people to go door to door testing people. I feel if there were those doors to door services to check blood sugar, hypertension in the home, it would help.” (Participant 37, central hospital chief nursing officer)
“From my point of view, I think if we could be having a hypertension clinic [. . .]We should be advising the people how to avoid high blood pressure. We should also monitor their BPs (blood pressures). Because with some people when you tell them to come again next week to recheck their BP, that is someone who came today with a high BP and we are giving a follow up date, many don’t come back. So perhaps if we were having BP clinics, they would know that on this particular day we refill our BP medications, so then everyone’s BP can be checked and we’d be able to follow them all.” (Participant 71, primary care facility medical assistant).
The participants also noted that inadequate health care funding influenced the implementation and coverage of NCD services. All the health facilities reported that they do receive lump sum funding for all the activities at the facility with no specific budget allocation for NCD care. The funding was thus perceived to be inadequate to carter for all needs at the facilities including NCD prevention and management interventions.
“The budget actually less than 20% goes to non-communicable diseases. Most of the money goes into communicable diseases. And mainly three diseases; malaria, TB, HIV. These hold almost 70% of the Ministry of Health budget. Only three diseases. And it’s also the emphasis for donors as well. So we are even discussing with donors to also open up for non-communicable diseases. They mostly focus on communicable diseases, because that’s where results are so fast. You convince who ever gave you the money that you have changed lives of these people, while non-communicable diseases the effect might happen in 40 years to come. And who will be there? When we buy drugs we just combine for the facility. But we are not really specific to say this money is for communicable, this money for non-communicable” (Participant 32, central hospital director)
Perceived needs for improving NCD care
Key informants cited staff shortages, the lack of capacity for junior staff to manage NCDs, shortage of drugs to treat NCDs and lack of adequate equipment to diagnose NCDs and provide follow up care for NCD clients.
a. Human resources
The common staff category of health care workers at the facilities were nursing and midwifery technicians (NMT), Health Surveillances Assistants (HSA), medical assistants and registered nurses and midwives (RNM). There were no medical specialists at primary or secondary care facilities. Many of the facilities did not have any nutritionists and radiology, laboratory or physiotherapy staff. Only 12 (0.5%) of the available healthcare workers from the sampled health facilities had attended an NCD management training in the last year. Figure 2 shows the percentage of facilities with different staff categories of health care workers.
Improving staff numbers and their capacity to manage NCDs was one of the needs that was highlighted by the key informants. It was only at the central hospitals where they had specialist nurses for different NCDs working in collaboration with medical team. NCD clinics at district hopitals and health centres were operated by clinical officers or medical assistants.
“The first need is the human reosurces. We have very few staff especially the clinicians” (Participant 55, central hospital medical officer).
“They [staff] are not enough, they are not well trained [. . .] it really affects the program because we want to reach out to many but like I have already said that in some of our Health Centers you find a clinician is afraid to prescribe some of the drugs [. . .] doesn’t know which drugs to give, to which type of let’s say hypertension. The first line, second line [. . .] which one to give, they are confused and they are afraid to prescribe, so you can have the medication in the pharmacy but they will not order, or it will expire” (Participant 2, deputy district director of health and social services)
b. Management guidelines
Available guidelines at the facilities were the Malawi Standard Treatment Guidelines (MSTG) [19] and the College of Medicine, Medicine department clinical book (Blue book) [20]. Fifteen (73%) facilities reported having guidelines for the managemenet of hypertension, diabetes, asthma and hyperlipicemia through the MSTG or the blue book. These guidelines were available as personal copies of the personel or facility copy. None of the facilities had management guidelines for alcohol or tobacco screening and treatment. The lack of NCD management guidelines at some of the facilities also affected client diagnosis and management.
“On my part, I have never seen any guidelines” (Participant 71, primary care facility medical assistant)
“For guidelines, we mostly use the Malawi Standard Treatment Guideline, because that’s the one that the government recommends. But for some of us that have exposure to working in the central hospitals, we have access to the blue books for internal medicine. So when we are teaching people about hypertension or diabetes we usually consult those books.”. (Participant 22, district hospital senior medical officer)
c. Drug supply
At the time of the assessment, none of the facilities had all 20 types of medications (Table 3) vital for managing NCDs in Malawi. Only 7 (32%) facilities (all urban) had at least half of the essential medicines available. Thiazide diuretics were the most commonly found antihypertensive, available at 90% of the facilities. Biguanides were the most commonly available drugs for diabetes available at 73% of the facilities. Insulin was only available at secondary and tertiary facilities. Sustained release theophylline tablets were the most commonly found drugs for treatment of asthma available at 91% of the facilities. Salbutamol and steroid hailers were reported available at 64% and 32% of the facilities respectively. Statins (drugs used for lowering cholesterol in the body) were only available at one facility. Aspirin (drug used to lower risk of clot formation) was available at 64% of the facilities in 300mg tablets and was dispensed as quarter tablets. At all the facilities, drug stockouts were common and were attributed to nonavailability of the medicines from the CMST at the time of odering. Table 3 shows the number of facilities that had different types of drugs used for management of NCDs, and number of facilities reporting stock outs in the last quarter. The table also includes the minimum level of healthcare facility permited to stock the drug, the therapeutic priority and procurement system code for the drugs according to the Malawi essential medicines list.
Table 3: Availability of NCD drugs at facilities
Class of drugs
|
Availability
N (%)
|
Stock out in the last quarter
N (%)
|
Expected level of availability*
|
Thrapeutic priority**
|
Procurement system code***
|
Anti-hypertensive drugs
|
|
|
|
|
|
Thiazide diuretic (e.g. hydrochlorothiazide)
|
20 (91)
|
8 (37)
|
Secondary
|
Vital
|
A
|
Calcium channel blocker (e.g. Nifedipine)
|
13 (59)
|
7 (32)
|
Secondary
|
Vital
|
A
|
Beta-blocker (e.g. Propranolol)
|
12 (55)
|
7 (32)
|
Secondary
|
Vital
|
A
|
ACE inhibitor (e.g. Captopril)
|
9 (41)
|
5 (23)
|
Tertiary
|
Vital
|
B
|
Others (e.g. Methyldopa, Hydralazine, Magnesium Sulphate)
|
11 (50)
|
3 (14)
|
Secondary
|
Essential
|
A
|
Diabetic drugs
|
|
|
|
|
|
Biguanides (e.g. Metformin)
|
16 (73)
|
6 (27)
|
Secondary
|
Vital
|
A
|
Sulfonylureas (e.g. Glibenclamide)
|
14 (64)
|
5 (23)
|
Secondary
|
Vital
|
A
|
Thiazolidinediones (e.g. Pioglitazone)
|
0 (0)
|
|
|
|
|
Dipeptidyl peptidase-4 inhibitors
|
0 (0)
|
|
|
|
|
Alpha-glucosidase inhibitors
|
0 (0)
|
|
|
|
|
Insulin type available
|
Ultra short-acting
|
2 (9)
|
0 (0)
|
|
|
|
Short-acting
|
6 (27)
|
0 (0)
|
Secondary
|
Vital
|
A
|
Intermediate
|
1(5)
|
0 (0)
|
|
|
|
Long-acting
|
5 (23)
|
0 (0)
|
Secondary
|
Vital
|
A
|
Other insulin (Biphasic)
|
1 (5)
|
0 (0)
|
|
|
|
Insulin syringes (e.g. U100)
|
5 (23)
|
4 (19)
|
|
|
|
Asthma
|
|
|
|
|
|
Short acting Beta2-agonists (salbutamol inhaler)
|
14 (64)
|
10 (45)
|
Primary
|
Vital
|
A
|
Anticholinergics (e.g. ipratropium bromide)
|
1(5)
|
0 (0)
|
|
|
|
Inhaler steroids (beclomethasone inhaler)
|
7 (32)
|
6 (27)
|
Tertiary
|
Vital
|
B
|
Oral steroids (e.g. oral predenisole)
|
16 (73)
|
1 (5)
|
Secondary
|
Vital
|
A
|
Long acting inhaled beta2 agosnist (e.g. salmeterol, formterol)
|
3 (14)
|
2 (9)
|
|
|
|
Sustained release theophylline tablets (e.g. aminophylline)
|
20 (91)
|
3 (14)
|
Primary
|
Vital
|
A
|
Leukotriene antagonists (e.g. monterlukast, zafirlukast)
|
0 (0)
|
|
|
|
|
For other diseases
|
|
|
|
|
|
Statins
|
1 (5)
|
0 (0)
|
Tertiary
|
Vital
|
A
|
Aspirin (300mg)
|
14 (64)
|
0 (0)
|
Primary
|
Vital
|
A
|
Key:
*Indicates the minimum level (primary, secondary or tertiary) of health facility at which the drug would normally be permitted for use. Exceptions are made when a prescriber with additional clinical expertise is available at a lower level facility. Arrangements can also be made for individual patients on mantainance treatment for chronic conditions to receive such treatment at a lower level facility [19].
** Drugs are categorized as vital, essential or non-essential. Vital drugs are potentially life saving, are a of major public health importance, and have significant withdrwal side-effects making regular supply mandatory. Essential drugs are effective against less ssevere but significant forms of illness. Non-essential drugs are those used for minor or self-limiting illnesses, have questionable efficacy, or have a highcost for a marginal therapeutic advantage [19].
***The drug procurement system has two codes, A and B. Code A is for drugs required for a large number of patients, routinely procured and stocked drugs at CMST. Code B is is for drugs required for a limited number of patients, not routinely procured and stocked by CMST. Payment for these drugs is made in advance by the ordering facility [19].
The key informants sited shortage of first line NCD drugs at health facilities as a major barrier to providing NCD care. Drug shortages were there due to stock outs of medicines at the central medical stores or delays in ordering drugs from the central medical stores. Drug ordering was the responsibility of the the facility and pharmacy in-charge. Eleven (50%) of the facilities reported that they do not get the drugs they ask for while 17 (77%) reported that they do not get the quantities of the drugs they ask for. In addition, national guidelines on drug supply restricts availability of some drugs at primary care facilities.
“The drugs are available, but we do experience a lot of stock outs. For hypertension we do have hydrochlorothiazide. That one is available. We have beta blockers like propranolol. For calcium channel blockers like nifedipine we don’t have but we do have it sometimes. For diabetes, metformin is available but glibenclamide is currently out of stock.” (Participant 43, district hospital pharmacist)
“We are the sole supplier of medicines and medical supplier to the public facilities. So if there is a stock out at a health facility there are a number of factors. Obviously number one is either we did not have at Central Medical Stores Trust, or the health facility did not order from us.” (Participant 17, Central Medical Stores Trust regional manager)
For diabetes, the medicine that we usually struggle with is the insulin. So if some patients require insulin, we are really not able to offer that service because according to policy, insulin is not stocked at health centers. (Participant 27, primary care facility medical officer)
d. Tests and procedures to detect, diagnose and monitor NCDs
Most facilities lacked basic equipment for diagnosing or managing NCDs. Only two facilities had equipment and capacity to conduct all six basic tests and procedures (Blood pressure, height, weight, glucose, blood lipids and urinalysis) recommended by WHO for early detection, diagnosis and monitoring of NCDs [17]. Twenty (91%) facilities had at least one digital sphygmomanometer that was functional and were able to conduct BP measurements. Nine (41%) facilities were checking weights at the adult outpatient department or NCD clinic. Only one facility (central hospital) had a spirometer, which is necessary equipment for making diagnosis of airflow limitation in asthma or COPD.
There was a statististically significant difference (p < 0.05) in the availability of medical imaging services according to health facility level. Many primary care facilities had limited capacity to conduct medical imaging services unlike the secondary or tertiary level facilities (Table 4).
Table 4: Availability of medical imaging services according to health facility level
Test
|
Central hospital N = 4
|
District Hospital N= 2
|
Health centre
N = 16
|
Total
N = 22
|
Ultrasound scanning
|
3 (75%)
|
2 (100%)
|
3 (19%)
|
8 (36 %)
|
Echocardiogram
|
3 (75%)
|
0 (0%)
|
1 (6%)
|
4 (18%)
|
electrocardiogram
|
4 (100%)
|
1 (50%)
|
0(0%)
|
5 (23%)
|
x-ray
|
3 (75%)
|
2 (100%)
|
1(6%)
|
6 (27%)
|
Doppler ultrasound
|
3 (75%)
|
1 (50%)
|
3 (19%)
|
7 (32%)
|
computed tomograph scan
|
3 (75%)
|
0 (0%)
|
0 (0%)
|
3 (14%)
|
All facilities reported or had a laboratory. Four (18%) of the facilities used HSA’s trained as laboratory assistants to conduct some tests. Eight (36%) of the laboratories had a functional centrifuge; 16 (73%) had a functional microscope. Only one central hospital laboratory was performing all the tests that were deemed necessary in diagnosis and monitoring for NCDs. Central and district hospitals had a more capacity for laboratory tests than the health centres. Table 5 shows the tests the laboratories were performing at the different levels of health facilities.
Table 5: Availability of laboratory tests at primary, secondary and tertiary facilities
TEST
|
Central HOSPITAL (N = 4)
|
District HOSPITAL (N = 2)
|
HEALTH CENTER
(N = 16)
|
Total
(N = 22)
|
Electrolytes (e.g. potassium)
|
3 (75%)
|
0 (0%)
|
1 (6%)
|
4 (18%)
|
Full blood count and differential
|
3 (75%)
|
2 (100%)
|
2 (13%)
|
7 (32%)
|
Full Urinalysis
|
3 (75%)
|
2 (100%)
|
4 (25%)
|
9 (41%)
|
Urine dipstick
|
3 (75%)
|
2 (100%)
|
8 (50%)
|
13 (59%)
|
Hb electrophoresis
|
2 (50%)
|
0 (0%)
|
3 (19%)
|
5 (23%)
|
HbA1c
|
1 (25%)
|
0 (0%)
|
1 (6%)
|
2 (9%)
|
Haemocult
|
2 (50%)
|
0 (0%)
|
2 (13%)
|
2 (18%)
|
Hemoglobin
|
3 (75%)
|
2 (100%)
|
6 (%)
|
11 (50%)
|
Lipid Profile
|
2 (50%)
|
0 (0%)
|
0 (0%)
|
2 (9%)
|
Liver Function Tests
|
3 (75%)
|
2 (100%)
|
1 (6%)
|
6 (27%)
|
Microalbuminuria
|
2 (50%)
|
0 (0%)
|
0 (0%)
|
2 (9%)
|
Random Blood Sugar
|
4 (100%)
|
2 (100%)
|
10 (63%)
|
16 (73%)
|
Glucometer
|
4 (100%)
|
2 (100%)
|
10 (63%)
|
16 (73%)
|
Automated analyzer
|
3 (75%)
|
2 (100%)
|
0 (0%)
|
5 (23%)
|
Renal Function Tests
|
3 (75%)
|
2 (100%)
|
1 (6%)
|
5 (27%)
|
Other available tests
|
|
|
HIV, MRDT, gene xpert, Cryptococcal antigen, CD4, Sputum microscopy, syphilis, HCG, Viral load, hormone tests (prostrate specific antigen)
|
The lack of basic equipment hindered on NCD care service provision as remarked by some of the key informants:
“For me equipment is the number one need. I know some may obviously say we need human resources. But even when you have all the human resource numbers you need, they can only do a little if they don’t have the necessary equipment to diagnose or treat patients" (Participant 31, central hospital specialist physician)
“We need equipment, the basics. Things like BP cuffs, urine dipsticks, and glucometers [. . ]. Of course we can also have some point of care tests like creatinine.” (Participant 14, primary care facility medical officer)
“Like for hypertension, it’s still a challenge due to equipment, especially the BP machines. We don’t have enough. Actually I’d say we don’t have any at all. We usually have a problem with batteries. So when a patient comes, we just attend to what they are complaining of without checking the BP, which is not a good practice. Because people expect that when they come here, their BP should be checked” (Participant 67, primary care facility medical assistant)
Only one facility however had a strong laboratory capacity and was able to do all the tests listed in Table 4.
“We have improved the laboratory, so it is able to do most of the tests. Actually our laboratory was assessed internally by ministry of health and we have four stars [. . .] the laboratory is supposed to have five stars. We are remaining with one more star. So we have a very good laboratory. The best in Malawi.” (Participant 32, central hospital director)
Limited NCD focused implementation research engagement
Key informants from academic institutions, MoH and the NCD BRITE partner institutions perceived that there was limited engagement in NCD focused implementation research. One reason for such limitation was the lack of funding for research locally. The MoH’s NCD unit does not receive any specific funding for research. Additionally, more seasoned researchers were already grounded in other areas of health research other than NCDs.
“I think lack of national funding bodies. Government putting in money for research . . . because of that we depend on international donors, and competition is stiff at international level. So it’s only those who have made it, those who have a name who are able to compete. But those who are just coming up, it’s not easy. The unfortunate part is that those people who have already made it, already have their niche, so it would be very difficult for them to start looking at other areas, because they already established in their area.” (Participant 1, university college research dean).
Another reason for minimal engagement in implementation research was lack of awareness and expertise in implementation science among some of the faculty members.
“As for me, I haven’t been involved in implementation research. But to my understanding, I that a research may be conducted, then you implement” (Participant 2, FGD 1).
“ We have a research centre. But I am not sure whether that [implementation research] is done. They should be in a better position to answer” (Participant 1, FGD 1).
Opportunities for improving NCD focused implementation research
Opportunities for improving NCD care and NCD focused implementation research exist at national and institutional level. In trying to improve NCD care in Malawi, the MoH introduced an NCD unit to oversee planning and implementation of NCD services in the country. The MOH also launched a National NCD action plan with a goal of reducing preventable and avoidable NCDs morbidity and mortality [21]. NCDs are also prioritized in other national documents and policies related to health:
NCDs are included in the National Health Policy, and the National Health Sector Strategic plan also mentions about NCDs. And even other sectors also talk about NCDs. For example, when you talk about the research part of it, we have the National Health Research Agenda which also prioritises NCDs. (Participant 28, MOH, Research unit)
“As an NCD and mental health unit, our objective is to make sure to respond to issues to do with NCD in this country. Our job is to find the burden of the disease and respond on how we can do the awareness. We also have the responsibility to make sure that the facilities where the people go to have the required human resource, equipment and medication. So basically we coordinate issues to do with NCD in this country”(Participant 29, MOH NCD unit)
NCD BRITE partner institutions and organizations that previously had a focus on other health problems like HIV or maternal health have a growing interest in NCDs. Broadening the scope of focus to include NCD has come about due rising incidence of NCD comorbidities with HIV as well as NCD complications in maternal health. The partner institutions in NCD BRITE consortium offer opportunities for capacity building for young researchers in implementation science through mentorship and internship positions.
“[We are] an organization which has unquestionable experience in relation to research so we can provide mentorship of investigators interested in NCDs. We are an organization which can also provide internship position for young investigators interested in NCDs. We have several years of proven record in mentorship in implementing research including evaluation of interventions.”(Participant 45, partner institution representative)
At the facility level, some improvements in human resource and diagnostic equipments has resulted in increased capacity to diagnose and treat NCDs.
The hospitals are also getting more prepared for these diseases. You know in the past were not getting busy to check for blood pressure, to check for sugar for patients, so it’s also development of the health system. Whereby we are able to send the patient to the laboratory, we are able to assess the patient much more comprehensively than we were doing before. With the coming in of a larger number of specialists which we used not to have in the past. So diagnostics is getting better, as well as the affluence of the people. (Participant 32, central hospital director)